Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Kimura disease is a benign and chronic inflammatory disorder of unknown etiology, occurring mainly in Asian countries (very rarely in Western countries) and predominantly affecting young men, that usually presents with a solitary or multiple non-tender subcutaneous masses in the head and neck region (in particular the preauricular and submandibular area) and/or generalized painless lymphadenopathy, often with salivary gland involvement. Characteristic laboratory findings include blood eosinophilia and markedly elevated serum immunoglobulin E (IgE) levels. It is often associated with autoinflammatory disorders (i.e. ulcerative colitis, bronchial asthma) and a co-existing renal disease.
Biomarker and diagnostic research for Kimura disease has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Kimura disease.
113 publications have been identified in PubMed for Kimura disease. Research spans Case Report / Case Series (62%), Review / Meta-Analysis (16%), and Other (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 70 | 62% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Kimura disease
18 |
16% |
Other research | 12 | 11% |
Clinical study results | 5 | 4% |
Testing and diagnosis research | 3 | 3% |
Laboratory research | 2 | 2% |
New treatment approaches | 2 | 2% |
Disease patterns and progression | 1 | 1% |
Yang R (2026). [PMID: 42174535](https://pubmed.ncbi.nlm.nih.gov/42174535/). *BMC Ophthalmol*. [Case Report / Case Series]
Luo SY (2026). [PMID: 37545246](https://pubmed.ncbi.nlm.nih.gov/37545246/). *Int J Low Extrem Wounds*. [Other]
Yang W (2026). [PMID: 41777898](https://pubmed.ncbi.nlm.nih.gov/41777898/). *Frontiers in immunology*. [Review / Meta-Analysis]
Zeng J (2026). [PMID: 41102876](https://pubmed.ncbi.nlm.nih.gov/41102876/). *J Dtsch Dermatol Ges*. [Case Report / Case Series]
Jesus PVS (2026). [PMID: 41733493](https://pubmed.ncbi.nlm.nih.gov/41733493/). *J Cutan Pathol*. [Review / Meta-Analysis]
Hou N (2026). [PMID: 40590108](https://pubmed.ncbi.nlm.nih.gov/40590108/). *Clin Nucl Med*. [Case Report / Case Series]
Chazal T (2026). [PMID: 41931074](https://pubmed.ncbi.nlm.nih.gov/41931074/). *J Allergy Clin Immunol Pract*. [Clinical Trial Publication]
Jin Y (2026). [PMID: 42167875](https://pubmed.ncbi.nlm.nih.gov/42167875/). *Kidney Int*. [Case Report / Case Series]
Teng YS (2026). [PMID: 41718032](https://pubmed.ncbi.nlm.nih.gov/41718032/). *Br J Dermatol*. [Case Report / Case Series]
Ambrosio B (2026). [PMID: 40781741](https://pubmed.ncbi.nlm.nih.gov/40781741/). *Int J Dermatol*. [Other]
AI-curated news mentioning Kimura disease
Updated Sep 11, 2026
A recent study published in PubMed highlights the magnetic resonance imaging findings in recurrent kimura disease affecting the unilateral parotid gland. This research contributes to the understanding of the disease's imaging characteristics.
Recent research highlights dupilumab as a targeted therapy for Th2-driven cutaneous manifestations in Kimura disease. This study suggests potential new treatment avenues for managing this rare condition.